Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Tag: paul stamets

business / mushrooms / psilocybin / research / state of the art

Investing in Psychedelics, Psilocybin, or Magic Mushrooms

[Updated October 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity after cannabis?  Many investors think yes. But it’s hard to invest in psychedelics (like …

Recent Posts

  • American Chemical Society Meeting – Only One Talk about Psychedelics?
  • Coffee with Psilocybin?
  • Psilocybin for Sale in Canada – Dana Larsen of the Medicinal Mushroom Dispensary
  • Chemical & Engineering News Discusses Entourage Effect
  • Review of the State of the Art for Microdosing Psychedelics

Recent Comments

  • Staff Scientist on Formulating New “Magic Mushroom” Compositions
  • Briab on Psilocybin Clinical Trials Approved by FDA
  • AD H on Psilocybin Clinical Trials Approved by FDA
  • brian on Formulating New “Magic Mushroom” Compositions
  • Philip Ehlen on Psilocybin Clinical Trials Approved by FDA

Archives

  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • aeruginascin
  • anxiety
  • business
  • cognitive enhancement
  • decriminalization
  • depression
  • law
  • legalization
  • mass
  • micro dosing
  • molecules vs. mushrooms
  • mushrooms
  • psilocin
  • psilocybin
  • psilocybin chemistry
  • psilocybin derivatives
  • Psilocybin Science
  • Psychedelic Science Review
  • research
  • state of the art
  • treatment
  • Uncategorized
  • unmet need
  • wood lover paralysis

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org
Copyright © 2019 Psilocybin Technology – OnePress theme by FameThemes